Genesee Capital Advisors LLC Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Genesee Capital Advisors LLC purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 34,824 shares of the company’s stock, valued at approximately $2,221,000. Acadia Healthcare comprises 1.1% of Genesee Capital Advisors LLC’s holdings, making the stock its 26th biggest holding.

A number of other hedge funds and other institutional investors have also made changes to their positions in ACHC. New Mexico Educational Retirement Board grew its position in shares of Acadia Healthcare by 18.6% in the second quarter. New Mexico Educational Retirement Board now owns 18,500 shares of the company’s stock valued at $1,161,000 after purchasing an additional 2,900 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of Acadia Healthcare by 9.5% in the second quarter. JPMorgan Chase & Co. now owns 4,406,100 shares of the company’s stock valued at $276,483,000 after purchasing an additional 380,515 shares during the last quarter. Advisor Resource Council acquired a new position in shares of Acadia Healthcare in the second quarter valued at approximately $621,000. Handelsbanken Fonder AB grew its position in shares of Acadia Healthcare by 22.9% in the second quarter. Handelsbanken Fonder AB now owns 15,574 shares of the company’s stock valued at $977,000 after purchasing an additional 2,900 shares during the last quarter. Finally, Amundi acquired a new position in shares of Acadia Healthcare in the second quarter valued at approximately $284,000.

Several equities analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft upped their target price on Acadia Healthcare from $62.00 to $70.00 and gave the company a “hold” rating in a research report on Wednesday, August 4th. Credit Suisse Group boosted their price target on Acadia Healthcare from $68.00 to $69.00 and gave the company an “outperform” rating in a research note on Monday, November 1st. UBS Group initiated coverage on Acadia Healthcare in a research note on Thursday, September 23rd. They issued a “buy” rating and a $81.00 price target for the company. TheStreet upgraded Acadia Healthcare from a “c+” rating to a “b” rating in a research note on Monday. Finally, Barclays initiated coverage on Acadia Healthcare in a research note on Thursday, August 12th. They issued an “underweight” rating and a $69.00 price target for the company. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $70.79.

NASDAQ ACHC opened at $61.25 on Thursday. The business has a fifty day moving average price of $61.37 and a two-hundred day moving average price of $62.76. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.41 and a quick ratio of 1.41. Acadia Healthcare Company, Inc. has a fifty-two week low of $41.68 and a fifty-two week high of $68.65. The stock has a market capitalization of $5.51 billion, a PE ratio of -8.22, a PEG ratio of 3.29 and a beta of 1.40.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, October 27th. The company reported $0.72 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.72. Acadia Healthcare had a positive return on equity of 12.14% and a negative net margin of 29.32%. The company had revenue of $587.60 million during the quarter, compared to analysts’ expectations of $591.42 million. During the same period in the prior year, the company earned $0.68 EPS. Acadia Healthcare’s revenue was down 29.5% compared to the same quarter last year. As a group, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 2.58 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services.

Featured Article: What are the benefits of a balanced fund?

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.